TACE
Clinical trials for TACE explained in plain language.
Never miss a new study
Get alerted when new TACE trials appear
Sign up with your email to follow new studies for TACE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for liver cancer patients with shunts: Drug-Coated beads vs. standard treatment
Disease control Recruiting nowThis Phase 3 trial tests whether drug-eluting beads (DEB-TACE) work better and are safer than standard chemoembolization (cTACE) for liver cancer patients who have had a TIPS procedure to manage complications of cirrhosis. The study will enroll 206 participants and compare surviv…
Matched conditions: TACE
Phase: PHASE3 • Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 22, 2026 12:00 UTC
-
New combo therapy aims to stop liver cancer return in High-Risk patients
Disease control Recruiting nowThis Phase 3 trial tests whether combining radiotherapy with the immunotherapy drug sintilimab can better prevent liver cancer from coming back after surgery, compared to the standard TACE procedure. The study enrolls 286 patients with high-risk features like narrow surgical marg…
Matched conditions: TACE
Phase: PHASE3 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 22, 2026 11:57 UTC
-
AI could revolutionize liver cancer care by predicting who needs extra treatment after surgery
Knowledge-focused Recruiting nowThis study is building an artificial intelligence (AI) model to help doctors decide which liver cancer patients should receive additional treatments like chemotherapy or targeted drugs after surgery. Researchers will analyze medical images and tissue samples from 11,000 patients …
Matched conditions: TACE
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:03 UTC